TMIC-13. EFFICACY OF RETINOIC ACID IN REVERSING IMMUNE EVASION IN IDH MUTANT GLIOMAS

Por Rao, Aparna, Zhang, Xiaoran, Kim, Jason, Kim, Youngmi, Holland, Eric, Amankulor, Nduka
Publicado no Neuro Oncol (2018)

DDIS-27. COMBINED INHIBITION OF NICOTINAMIDE PHOSPHORIBOSYLTRANSFERASE (NAMPT) AND POLY (ADP-RIBOSE) POLYMERASE (PARP) IMPAIRS GLIOBLASTOMA CELL GROWTH

Por Hwang, Lee, Su, Yu-Ting, Vogelbaum, Michael, Gilbert, Mark, Wu, Jing
Publicado no Neuro Oncol (2018)

IMMU-37. VEMURAFENIB ENHANCES THE CYTOTOXICITY OF NY-ESO-1 TCR ENGINEERED T-CELLS FOR BRAF MUTANT BRAIN TUMORS

Por Bethel, Jacob, Aliche, Julian, Orpilla, Joey, Soto, Horacio, Everson, Richard, Davidson, Tom, Wang, Anthony, Liau, Linda, Prins, Robert
Publicado no Neuro Oncol (2018)

PATH-04. MDM2/4 AMPLIFICATION AND RISK OF HYPERPROGRESSION IN HIGH-GRADE GLIOMAS TREATED WITH CHECKPOINT INHIBITORS

Por Donovan, Laura, Schulte, Jessica, Kreisl, Teri, Welch, Mary, B. Lassman, Andrew, Iwamoto, Fabio
Publicado no Neuro Oncol (2018)

ANGI-07. 5ALA FLUORESCENCE BASED SORTING IDENTIFIES SERPINE1 AS A NOVEL THERAPEUTIC TARGET ON INVASIVE GBM CELLS

Por Rowlinson, Jonathan, Estevez Cebrero, Maria de los Angeles, Lourdusamy, Anbarasu, Rahman, Ruman, Smith, Stuart
Publicado no Neuro Oncol (2018)

TMIC-21. THE POTENTIAL CONTRIBUTION OF PERICYTES TO GLIOBLASTOMA MULTIFORME TUMOUR MICRO-ENVIRONMENT IMMUNOSUPPRESSION VIA DAMPENED EXPRESSION OF ICAM-1, VCAM-1 AND MCP-1

Por Macapagal, Jena, Park, Thomas, Joret, Maximillian, Rustenhoven, Justin, Dieriks, Birger, Faull, Richard, Schweder, Patrick, Dragunow, Mike
Publicado no Neuro Oncol (2018)

IMMU-39. FIRST-IN-KIND T CELLS CARRYING A CHIMERIC ANTIGEN RECEPTOR AGAINST AN EXTRACELLULAR MATRIX PROTEIN TARGET GLIOBLASTOMA CELLS AND SHOW ANTI-TUMOR EFFICACY

Por Sengupta, Sadhak, Nandhu, Mohan, Longo, Sharon, Sengupta, Sudarshana, Longo, John, Sampath, Prakash, Viapiano, Mariano
Publicado no Neuro Oncol (2018)

NIMG-55. RADIOMICS ANALYSIS FOR DETECTION OF IDH MUTATION OF GLIOMA USING DIFFUSION TENSOR AND KURTOSIS IMAGES

Por Takahashi, Satoshi, Takahashi, Wataru, Tanaka, Shota, Haga, Akihiro, Nakamoto, Takahiro, Mukasa, Akitake, Takayanagi, Shunsaku, Suzuki, Yuichi, Koike, Tsukasa, Kitagawa, Yosuke, Hana, Taijyun, Nejo, Takahide, Nomura, Masashi, Saito, Nobuhito
Publicado no Neuro Oncol (2018)

ACTR-42. THE USE OF ADVANCED DIFFUSION MRI PARAMETERS IN THE ASSESSMENT OF TREATMENT RESPONSE IN GLIOBLASTOMA USING MULTI-B VALUE ACQUISITION AND A HISTOGRAM-BASED APPROACH

Por Islam, Shah, Morrison, Melanie, Grech-Sollars, Matthew, Orton, Matthew, Waldman, Adam
Publicado no Neuro Oncol (2018)

TMIC-20. INTERSTITIAL FLUID FLOW MAGNITUDES DRIVE CHANGES TO THE GLIOMA MICROENVIRONMENT

Por Kingsmore, Kathryn, Stine, Caleb, Cornelison, R Chase, Abler, Daniel, Rockne, Russell, Munson, Jennifer
Publicado no Neuro Oncol (2018)

ACTR-45. PHASE 0/2 STUDY OF RIBOCICLIB IN PATIENTS WITH RECURRENT GLIOBLASTOMA

Por Tien, An-Chi, Bao, Xun, Derogatis, Alanna, Kim, Seongho, Mehta, Shwetal, Li, Jing, Sanai, Nader
Publicado no Neuro Oncol (2018)

PATH-06. QUANTITATIVE ANALYSIS OF MGMT PROMOTER METHYLATION AND ITS PROGNOSTIC VALUE IN GLIOBLASTOMA MULTIFORME (GBM) PATIENTS TREATED WITH ALKYLATING CHEMOTHERAPY- PRELIMINARY REP...

Por Bajwa, Samarjeet, Flanagan, Lisa, Hernandez, Stephania, Beverly Fu, Dan, Bota, Daniela, Kong, Xiao-Tang
Publicado no Neuro Oncol (2018)

TMIC-22. EXOSOMAL NON-CODING RNAS MEDIATE THE CROSS-TALK OF BRAIN METASTASIS CANCER STEM CELLS AND MICROGLIA

Por Cazacu, Simona, Jiang, Wei, Xiang, Cunli, Hammoud, Zane, Scarpace, Lisa, Kalkanis, Steven, Brodie, Chaya
Publicado no Neuro Oncol (2018)

EXTH-79. BEVACIZUMAB, IRINOTECAN, TEMOZOLOMIDE, TYROSINE KINASE INHIBITION, AND MEK INHIBITION ARE EFFECTIVE AGAINST PLEOMORPHIC XANTHOASTROCYTOMA REGARDLESS OF V600E STATUS

Por Thompson, Eric, Landi, Daniel, Ashley, David, Keir, Steve, Bigner, Darell
Publicado no Neuro Oncol (2018)

PATH-07. PRONEURAL GLIOMAS ARE ASSOCIATED WITH POOR SURVIVAL AND MORE LIKELY LOCATED IN PROXIMITY TO THE SUB-VENTRICULAR ZONE

Por Joshi, Rushikesh, Alattar, Ali, Chen, Clark
Publicado no Neuro Oncol (2018)

TMIC-27. GLIOMA CELLS INDUCE ‘EPIGENETIC MEMORY’ IN MICROGLIA AND BLOCK INFLAMMATORY GENE EXPRESSION- IN VITRO AND IN VIVO FINDINGS

Por Kaminska, Bozena, Maleszewska, Marta, Steranka, Aleksandra, Smiech, Magdalena, Kaza, Beata, Pilanc, Paulina, Dabrowski, Michal
Publicado no Neuro Oncol (2018)

PATH-08. THE IVY GLIOBLASTOMA PATIENT ATLAS - A NOVEL CLINICAL AND RADIO-GENOMICS RESOURCE FOR EARLY PHASE CLINICAL TRIAL DESIGN AND INTERPRETATION

Por Ligon, Keith, Lupo, Janine, Molinaro, Annette, Block, Shannon, Charbonneau, Sarah, Geduldig, Jack, Stemmer-Rachamimov, Anat, DeAngelis, Lisa, Yong, William, Schultz, Nikolaus, Young, Robert, Huang, Raymond, Chang, Susan, Arrillaga-Romany, Isabel, Alexander, Brian, Reardon, David, J Phillips, Joanna, de Groot, John, Cloughesy, Timothy, Colman, Howard, Prados, Michael, Wen, Patrick, Butowski, Nicholas, Mellinghoff, Ingo, Ellingson, Benjamin
Publicado no Neuro Oncol (2018)

IMMU-42. TTFIELDS INDUCES IMMUNOGENIC CELL DEATH AND STING PATHWAY ACTIVATION THROUGH CYTOPLASMIC DOUBLE-STRANDED DNA IN GBM

Por Chen, Dongjiang, Thomas, Nagheme, Ren, Jie, Le, Son, Deng, Changwang, Jin, Dan, Sebastian, Mathew, Nguyen, Duy, Tran, David
Publicado no Neuro Oncol (2018)

EXTH-81. TARGETING Nrf2 ANTIOXIDATIVE PATHWAY AS A NOVEL THERAPEUTIC STRATEGY FOR IDH1-MUTATED CANCERS

Por Liu, Yang, Lu, Yanxin, Celiku, Orieta, Li, Aiguo, Yang, Chunzhang
Publicado no Neuro Oncol (2018)

ACTR-49. PriCoTTF: A PHASE I/II TRIAL OF TUMOR TREATING FIELDS PRIOR AND CONCOMITANT TO RADIOTHERAPY IN NEWLY DIAGNOSED GLIOBLASTOMA

Por Glas, Martin, Scheffler, Björn, Lazaridis, Lazaros, Herrlinger, Ulrich, Pierscianek, Daniela, Sure, Ulrich, Proescholdt, Martin, Hau, Peter, Hense, Jörg, Kleinschnitz, Christoph, Grosu, Anca-Ligia, Stuschke, Martin, Kebir, Sied
Publicado no Neuro Oncol (2018)